Laboratory Corporation of America Holdings
SWB:LAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Laboratory Corporation of America Holdings
SWB:LAB
|
US |
|
C
|
Close Brothers Group PLC
OTC:CBGPY
|
UK |
|
Gecina SA
F:GI6A
|
FR |
|
A
|
Ascendis Pharma A/S
SWB:A71
|
DK |
|
NN Group NV
AEX:NN
|
NL |
|
D
|
Dampskibsselskabet Norden A/S
SWB:D69
|
DK |
|
Community West Bancshares
NASDAQ:CWBC
|
US |
Wall St Price Targets
LAB Price Targets Summary
Laboratory Corporation of America Holdings
According to Wall Street analysts, the average 1-year price target for LAB is 240.52 EUR with a low forecast of 207.64 EUR and a high forecast of 278.92 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LAB's stock price target?
Price Target
240.52
EUR
According to Wall Street analysts, the average 1-year price target for LAB is 240.52 EUR with a low forecast of 207.64 EUR and a high forecast of 278.92 EUR.
What is the Revenue forecast for Laboratory Corporation of America Holdings?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Laboratory Corporation of America Holdings?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Laboratory Corporation of America Holdings?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 5 years is 18%.
